Cross Border Impact Ventures aims to be the preferred investor for transformative health technology companies with the potential of meeting the needs of women, children and adolescents across global markets. We have partnered with Grand Challenges Canada to develop a world class platform that breaks the paradigm of who benefits from leading technologies.
External link for Cross-Border Impact Ventures
661 University Avenue, MaRs Centre, West Tower
Suite 1720
Toronto, Ontario M5G 1M1, CA
Congratulations to Neil Ray, Russ DeLonzor and the Raydiant Oximetry, Inc. team! What an accomplishment!
We are delighted to win this rigorous challenge and we are eager to leverage the prize money to further our fetal pulse oximetry technology! Neil Ray Russ DeLonzor
Congratulations to Daye for the feature in TIME's list of groundbreaking inventions that are changing how we live, work, play, and think about what’s possible!
Our Diagnostic Tampon has been recognised on TIME’s Best Inventions of 2024 list! 🌟 With our revolutionary design, we’re changing the way you care for your vaginal health. Our diagnostic tampon offers easy, at-home screening for STIs, HPV, fertility markers and microbiome monitoring. No more clinic visits, waiting lists and invasive procedures. This is about more than providing high-quality care, it’s about putting the power back into women’s hands. TIME's recognition is a proud moment for us at Daye. We’re excited to continue paving the way for a better future in gynae health! Discover the full list https://lnkd.in/ekZTJCpd #TIMEBestInventions #HealthInnovation #GynaeHealth
Managing Partner Annie Theriault attended the World Health Summit 2024 in Berlin this week. The discussions around "Building Trust for a Healthier World" were both inspiring and timely, and it was great to connect with leaders across politics, science, the private sector, and civil society, all working toward innovative solutions for global health. Plus, it is always a treat to spend time with the leaders from our portfolio, like Michelle Gomes! We look forward to applying these insights to drive impact in our firm! #WHS2024 #GlobalHealth #Innovation
Thrilled for Raydiant Oximetry, Inc.'s well-deserved opportunity to partner with a foundation that is completely aligned with their vision to make a lasting difference in maternal and fetal health worldwide. Looking forward to the exciting developments on Lumerah that will come out of this work!
We are honored to be the recipient of a $1M grant from the Bill & Melinda Gates Foundation for the development of our Lumerah technology. Neil Ray Russ DeLonzor
Cross-Border Impact Ventures will be in New York this week for the 79th session of the United Nations General Assembly (UNGA). We are looking forward to reconnecting with and learning from partners and leaders around the world! If you are: - An early growth stage women's or children's health tech founder💡 - A fellow health tech investor 🌱 - Interested in the work we are doing to increase access to health technologies for women and children globally 🌍 Reach out to Annie Theriault, Cyriac M Alappat CPA,CA or Hannah Sharpe on LinkedIn and we will try our best to catch you at UNGA, or shortly thereafter! #UNGA #UNGA79 #UnitedNations #SDGs #HealthForAll
💡Did you know?💡 Pulse oximetry technology is used to diagnose low oxygen levels in virtually every clinical setting, but no such technology has existed for fetuses in the labour ward. In fact, current fetal monitoring technology is no more accurate than a coin toss when it comes to predicting fetal distress. Enter Lumerah™ by Raydiant Oximetry, Inc. - a low-cost and non-invasive medical device that monitors fetal oxygenation during labour. This month, we were grateful to shine a spotlight on the strides Raydiant Oximetry is making towards reducing unnecessary emergency C-sections and improving outcomes for both mother and baby. Read Annie Theriault's article on Raydiant Oximetry's groundbreaking technologies below. ⬇️
"Continued #investment in transformative healthcare companies with a global lens can propel further progress in maternal and newborn health. Access to better health technology that transcends borders will benefit women, children, and the world at large" - Annie Theriault, managing partner, Cross-Border Impact Ventures: https://lnkd.in/e5hBx9v5 #femtech #maternalhealth #womenshealth
Annie Theriault is looking forward to representing Cross-Border Impact Ventures on stage at the Women's Private Capital Summit Canada this week! Annie, who leads the charge on CBIV's fundraising, will discuss the Do’s and Don’ts, the right approach to fund size targets and hard caps, as well as how other terms are evolving alongside Anastasia Elia, CFA, Lauren Harris, Leslie Hill and Stephanie Lo, CPA. With Intelligence - Women's Summits #WPCSCanada2024 #privatecapital #womeninvesting
We’re thrilled to share that Samsung Medison has officially acquired Sonio following approval from the French Ministry of Economy & Finance! Combining Sonio’s AI software with Samsung’s ultrasound products will lead to improved prenatal exam quality, efficiency, and ultimately improve maternal and newborn health globally. Congrats to Cecile Brosset Dubois, Remi Besson, David Amouyal, Deepak Prakash, Dagmar Nuber and the entire Sonio team! We are so proud to have led Sonio's Series A round of €13 and invested with a fantastic group of co-investors Elaia (Céline Passedouet, Sacha Loiseau), Bpifrance (Eva Clerc), OneRagtime (Stephanie Hospital, Pauline d'Arthuys), European Innovation Council and SMEs Executive Agency (EISMEA) (Maxime Pawlowski) and congrats to (Annie Theriault, Megan Dover, P.Eng., MBA) from our team at Cross-Border Impact Ventures. As part of this acquisition, a grant was awarded to Ilara Health to deploy point-of-care ultrasound (POCUS) devices in primary care facilities in Kenya with the impact objective to improve maternal and newborn healthcare delivery. Sonio will also continue scale its business independently, developing software products compatible with all ultrasound equipment manufacturers, pursuing their vision of the quality of prenatal care. Read the full announcement here: https://lnkd.in/ejfVhrEY
Cross-Border Impact Ventures reposted this
Annie Theriault, managing partner at Cross-Border Impact Ventures, shares the five most promising women's health trends to watch in 2024. https://lnkd.in/gJzWzFN4 #health #wellbeing #womenshealth #reproductivehealth #hormonalhealth #sexualhealth #pregnancyhealth #tech #healthtech #femtech #innovation #digitalhealth #womenintech #womeninbusiness #trends #2024
🌟 Exciting News Alert! 🌟 The Cross-Border Impact Ventures team is thrilled to announce the promotion of Megan Dover, P.Eng., MBA to Junior Partner! As Principal and Co-founder of CBIV, Megan has been an integral part of our journey from the very beginning. Her expertise in impact and angel investing, venture advisory, and business strategy has been invaluable in shaping the early thesis of our fund and launching our firm. Before joining CBIV, Megan played key roles in corporate finance and strategy for a publicly traded mining and infrastructure company, worked in management consulting for a global firm, and even ventured into R&D for a biotech startup. Her diverse experience brings such a unique perspective to our team. Megan is also active in her own community - her role as an advisor and angel investor at the Creative Destruction Lab (CDL) in Toronto highlights her passion for nurturing innovation and supporting entrepreneurs, even in her spare time. Megan, your promotion is incredibly well-deserved, and we are truly thankful for your contributions to CBIV. Your leadership, expertise, and commitment to our mission is inspiring, and we look forward to achieving even greater heights together. Congratulations, Megan! 🚀